An All-Solid Wirelessly Rechargeable Battery for a Fully Internal Cochlear Implant
用于全内置人工耳蜗的全固态无线充电电池
基本信息
- 批准号:10253607
- 负责人:
- 金额:$ 39.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAffectAgingAnatomyAnodesAuditoryBiocompatible MaterialsBiological Response Modifier TherapyBluetoothBypassCathodesCellsChargeCochlear ImplantsCoinCoupledCouplesCraniocerebral TraumaCuesCustomCypressDevelopmentDevicesDiseaseEarEconomic BurdenElectrolytesEnsureEyeFDA approvedFundingHealthHearingHearing AidsHeredityImidesImplantInstitutesIronLeadLearningLegal patentLifeLiquid substanceLithiumMassachusettsMastoid processMedicalMedical DeviceMonitorOperative Surgical ProceduresOutputPatientsPerformancePhasePolyethylene GlycolsPopulationPower SourcesProductivityProsthesisQuality of lifeResistanceRiskRouteSafetySensorineural Hearing LossSkinSleepSmall Business Innovation Research GrantSolidSurgeonSurveysSwimmingSystemTechnologyTemperatureTestingTimeTrainingWaterWireless TechnologyWorkWorkplaceanalogbasebonecostcraniumdesigndisabilityexternal ear auricleinnovationinorganic phosphatemicrophonemigrationototoxicitypreventprototyperadio frequencyremote sensingsealsensorsignal processingsocial stigmasoundtransmission processvoltage
项目摘要
PROJECT SUMMARY
Severe to profound sensorineural hearing loss (SNHL), caused by disease, aging, ototoxicity,
head trauma and heredity, affects about 60 million worldwide, and is expected to reach around
100 million by 2050. This disability leads to a significantly lowered quality of life and a large
economic burden, estimated to be around $750 billion worldwide, coming from health sector
costs, educational support, and loss of workplace productivity. For this population, amplification
with even the most sophisticated hearing aids is usually ineffective, and restorative biological
therapies are years away. A cochlear implant is currently the only available route for restoring
‘adequate’ functionality. Only 600,000 implants have been done worldwide till 2019, and about
50,000 devices are being sold annually. This large discrepancy between those that can benefit
and those that actually get the implant is driven partly by their cost, availability and the lack of
trained surgeons and facilities. However, there are several limitations in the current devices that
contribute to very low adoption: (a) The highly visible unit attached to the skull outside the
mastoid bone, connected by a cable to the sound processor and rechargeable battery placed
behind the ears, makes the disability very obvious, and creates an unacceptable social stigma
for many patients, causing them to refuse this option; (b) Sound filtering by the auricle and
auditory canal is bypassed because of the external microphone, introducing unnatural cues; (c)
The device typically must be taken off during showering or swimming (although a few water-
resistant versions are now available), and during sleeping, increasing the likelihood of damage,
misplacement, or the ability to hear in these situations; (d) Having an external magnet that
couples and aligns the internal and external components can lead to skin breakdown and
implant extrusion; (e) The large footprint and placement leaves open the risk for device
migration requiring revision surgery. A fully internal cochlear implant (FICI), that does not have
any behind the ear components, would address this large unmet medical need.
There are no FICIs currently approved by the FDA. The lack of a self-contained power supply is
a key roadblock preventing realization of all FICIs. Through innovations in circuit design and
signal processing, collaborating groups at Massachusetts Eye and Ear and Massachusetts
Institute of Technology have developed, tested and patented a low power (1 mW) system-on-a-
chip (SoC) for a FICI, a critical advance. Current rechargeable batteries have organic liquid
electrolytes making them unsafe for this application. With SBIR Phase I funding, Audiance, Inc.
has shown proof of concept of an all-solid single-stack cell that is the building block for a battery
that meets the electrochemical, safety and footprint requirements for a FICI. The focus of this
SBIR Phase II project is to build a multi-stack wirelessly rechargeable battery and integrate it
with a battery management system that senses the state of health of the battery and controls
the charge profile to provide timely charging and maximum battery life. The all-solid LIB will
remove a critical roadblock for the development of a FICI, and thus open up an opportunity to
help millions of patients around the world with severe to profound SNHL. The learning from the
design and fabrication of this battery will allow Audiance to customize batteries for a range of
other active implantable medical devices.
项目摘要
重度至极重度感音神经性听力损失(SNHL),由疾病、衰老、耳毒性,
头部创伤和遗传,影响全球约6000万人,预计将达到约
到2050年达到1亿。这种残疾导致生活质量显著降低,
经济负担,估计全世界约为7 500亿美元,来自卫生部门
成本,教育支持和工作场所生产力的损失。对于这个群体,
即使是最复杂的助听器通常也是无效的,
治疗还需要很多年人工耳蜗是目前唯一可行的恢复
“足够”的功能。到2019年,全球仅完成了60万例植入手术,
每年销售5万台设备。这一巨大的差异在那些能够受益于
而那些真正得到植入物的人部分是由他们的成本,可用性和缺乏
训练有素的外科医生和设施。然而,在当前设备中存在几个限制,
导致采用率非常低:(a)高度可见的单位连接到头骨外,
乳突骨,通过电缆连接到声音处理器和放置的可充电电池
在耳朵后面,使残疾非常明显,并造成不可接受的社会耻辱
对于许多患者,导致他们拒绝这种选择;(B)通过耳廓进行声音过滤,
由于外部麦克风,耳道被绕过,从而引入不自然的线索;(c)
该装置通常必须在淋浴或游泳期间取下(尽管有一些水-
抗性版本现在可用),并且在睡眠期间,增加了损坏的可能性,
(d)有一个外部磁铁,
耦合和对齐内部和外部组件会导致皮肤破裂,
植入物挤出;(e)较大的占地面积和放置位置可能会导致器械风险
移位需要翻修手术。全内置人工耳蜗(FICI),没有
任何耳后组件,将解决这一巨大的未满足的医疗需求。
目前没有FDA批准的FICI。由于缺乏自备电源,
这是阻止实现所有FICI的关键障碍。通过电路设计的创新,
信号处理,马萨诸塞州眼耳和马萨诸塞州的合作小组
技术研究所开发,测试和专利的低功耗(1毫瓦)系统上的一个,
芯片(SoC)的FICI,一个关键的进步。目前的可再充电电池具有有机液体
电解质使得它们对于该应用不安全。随着SBIR第一阶段的资金,Audiance,Inc.
已经证明了全固体单堆电池的概念,这是电池的构建块
符合FICI的电化学、安全和占地面积要求。的重点
SBIR第二阶段项目是建立一个多堆栈无线充电电池和集成它
具有电池管理系统,其感测电池的健康状态并控制
充电模式,以提供及时充电和最大的电池寿命。全固态锂离子电池将
为FICI的发展扫除了一个关键的障碍,从而打开了一个机会,
帮助世界各地数百万患有重度至深度SNHL的患者。学习的过程
这种电池的设计和制造将使Audiance能够为一系列
其他有源植入式医疗器械。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Molinski其他文献
Michael Molinski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Molinski', 18)}}的其他基金
An All-Solid Wirelessly Rechargeable Battery for a Fully Internal Cochlear Implant
用于全内置人工耳蜗的全固态无线充电电池
- 批准号:
10369703 - 财政年份:2019
- 资助金额:
$ 39.33万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Standard Grant